-
21
PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma
Published 2025-02-01Subjects: “…Hepatocellular carcinoma (HCC)…”
Get full text
Article -
22
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma
Published 2025-02-01Subjects: “…hepatocellular carcinoma (HCC)…”
Get full text
Article -
23
AdipoR1 enhances the radiation resistance via ESR1/CCNB1IP1/cyclin B1 pathway in hepatocellular carcinoma cells
Published 2025-01-01Subjects: “…HCC…”
Get full text
Article -
24
Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancer
Published 2025-01-01Subjects: “…Hepatocellular carcinoma (HCC)…”
Get full text
Article -
25
Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis
Published 2025-02-01Subjects: “…hepatocellular carcinoma (HCC)…”
Get full text
Article -
26
MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells
Published 2025-01-01Subjects: “…hepatocellular carcinoma (HCC)…”
Get full text
Article